The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Gastroenterology & Hepatology in conversation with

By The Lancet GroupMedicineHealth & Fitness
Download on the App Store

The Lancet Gastroenterology & Hepatology in conversation with episodes

  • UDCA Response Score

    Marco Carbone talks to The Lancet Gastroenterology & Hepatology about predicting treatment response for patients with primary biliary cholangitis

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    10 min
  • Global prevalence, treatment, and prevention of hepatitis B virus infection

    Homie Razavi and Devin Razavi-Shearer join The Lancet Gastroenterology & Hepatology to discuss their HBV modelling study.

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    14 min
  • Neoplasia detection in ulcerative colitis

    Jasper Vleugels joins The Lancet Gastroenterology and Hepatology to discuss the results of the FIND-UC trial.

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    9 min
  • Functional dyspepsia

    Imran Aziz discusses his paper on functional dyspepsia, which is published in the April issue of The Lancet Gastroenterology & Hepatology.

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    11 min
  • Can DAA therapy for HCV reactivate HBV in coinfected patients?

    In this Lancet Gastroenterology & Hepatology podcast, Johannes Vermehren discusses the risks of Hepatitis B reactivation in coinfected patients receiving treatment for Hepatitis C.

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    7 min
  • Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018

    Sandra Andorf and Kari Nadeau discuss their work on anti-IgE treatment with oral immunotherapy in multifood allergic participants.

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    19 min
  • PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017

    Jeffrey Hyams discusses the PROTECT study, which looks at outcomes in paediatric ulcerative colitis.

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    12 min
  • Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017

    Yeng Ang and James Britton discuss setting research priorities for future work in Barrett's oesophagus and gastro-oesophageal reflux disease

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    22 min
  • Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017

    Adrian Miranda talks about his work on using neurostimulation as a method for addressing abdominal pain-related functional gastrointestinal disorders in children.

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    10 min

About The Lancet Gastroenterology & Hepatology in conversation with

From the publisher's feed

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare,…

More shows like The Lancet Gastroenterology & Hepatology in conversation with

American Journal of Gastroenterology Author Podcasts by American College of Gastroenterology

American Journal of Gastroenterology Author Podcasts

70 Listeners

Health Report by ABC Australia

Health Report

128 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

21 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

1 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

Evidence-Based GI: An ACG Publication and Podcast by American College of Gastroenterology

Evidence-Based GI: An ACG Publication and Podcast

18 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health Western Pacific in conversation with by The Lancet Group

The Lancet Regional Health Western Pacific in conversation with

0 Listeners

7 minute Hepatology by Rohit Gupta

7 minute Hepatology

0 Listeners

The Lancet Primary Care in conversation with by The Lancet Group

The Lancet Primary Care in conversation with

0 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners